4
Changes in Ownership
IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-25-019235
SVP, CMO, Head-Res&Drug sold 41,269 shares at $1.76 ($72,633)
- SVP, CMO, Head-Res&Drug acquired 133,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shetzline Michael SVP, CMO, Head-Res&Drug | 2025-02-10 | Grant or award | +133,333 | 595,276 | D | ||
| Shetzline Michael SVP, CMO, Head-Res&Drug | 2025-02-10 | Sale | −41,269 | $1.76 | $72,633 | 554,007 | D |
| Open-market sales · 41,269 sh · avg $1.76 · $72,633 | |||||||
Loading xslF345X05/ownership.xml…